428 related articles for article (PubMed ID: 25541296)
1. Evolution of pneumococcal infections in adult patients during a four-year period after vaccination of a pediatric population with 13-valent pneumococcal conjugate vaccine.
Payeras A; Villoslada A; Garau M; Salvador MN; Gallegos MC
Int J Infect Dis; 2015 Apr; 33():22-7. PubMed ID: 25541296
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of penicillin non-susceptible Streptococcus pneumoniae isolated before and after pneumococcal conjugate vaccine implementation in Casablanca, Morocco.
Diawara I; Barguigua A; Katfy K; Nayme K; Belabbes H; Timinouni M; Zerouali K; Elmdaghri N
Ann Clin Microbiol Antimicrob; 2017 Apr; 16(1):23. PubMed ID: 28376809
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
[TBL] [Abstract][Full Text] [Related]
4. Pneumococcal infections in elderly patients attending hospital since PCV-13 authorization in Spain.
Payeras A; Peñaranda M; Iñigo A; Garau M; Luis Pérez J; Gallegos C; Riera M
Infect Dis (Lond); 2017 Jan; 49(1):71-80. PubMed ID: 27686179
[TBL] [Abstract][Full Text] [Related]
5. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
Mokaddas E; Albert MJ
Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
[TBL] [Abstract][Full Text] [Related]
6. Serotype distribution of Streptococcus pneumoniae in children with invasive diseases in Turkey: 2008-2014.
Ceyhan M; Ozsurekci Y; Gürler N; Öksüz L; Aydemir S; Ozkan S; Yuksekkaya S; Keser Emiroglu M; Gültekin M; Yaman A; Kiremitci A; Yanık K; Karli A; Ozcinar H; Aydin F; Bayramoglu G; Zer Y; Gulay Z; Gayyurhan ED; Gül M; Özakın C; Güdücüoğlu H; Perçin D; Akpolat N; Ozturk C; Camcıoğlu Y; Karadağ Öncel E; Çelik M; Şanal L; Uslu H
Hum Vaccin Immunother; 2016; 12(2):308-13. PubMed ID: 26325175
[TBL] [Abstract][Full Text] [Related]
7. Change in Pneumococcus Serotypes but not Mortality or Morbidity in Pre- and Post-13-Valent Polysaccharide Conjugate Vaccine Era: Epidemiology in a Pediatric Intensive Care Unit over 10 Years.
Hon KL; Chan KH; Ko PL; Cheung MHY; Tsang KYC; Chan LCN; Chan RWY; Leung TF; Ip M
J Trop Pediatr; 2018 Oct; 64(5):403-408. PubMed ID: 29126217
[TBL] [Abstract][Full Text] [Related]
8. Distribution of Streptococcus pneumoniae serotypes in the northeast macro-region of São Paulo state/Brazil after the introduction of conjugate vaccine.
Medeiros MIC; Almeida SCG; Guerra MLLS; da Silva P; Carneiro AMM; de Andrade D
BMC Infect Dis; 2017 Aug; 17(1):590. PubMed ID: 28841854
[TBL] [Abstract][Full Text] [Related]
9. Streptococcus pneumoniae carriage among febrile children at the time of PCV-10 immunization in pediatric emergencies at Mohammed VI University Hospital Centre in Marrakesh (Morocco).
Dilagui I; Moussair FZ; Loqman S; Diawara I; Zerouali K; Belabbes H; Zouhair S; Bourouss M; Bouskraoui M; Soraa N
Arch Pediatr; 2019 Nov; 26(8):453-458. PubMed ID: 31645292
[TBL] [Abstract][Full Text] [Related]
10. Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa.
Tempia S; Wolter N; Cohen C; Walaza S; von Mollendorf C; Cohen AL; Moyes J; de Gouveia L; Nzenze S; Treurnicht F; Venter M; Groome MJ; Madhi SA; von Gottberg A
BMC Infect Dis; 2015 Oct; 15():450. PubMed ID: 26496761
[TBL] [Abstract][Full Text] [Related]
11. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.
Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J
Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501
[TBL] [Abstract][Full Text] [Related]
12. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
[TBL] [Abstract][Full Text] [Related]
13. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children.
Ruiz-Contreras J; Picazo J; Casado-Flores J; Baquero-Artigao F; Hernández-Sampelayo T; Otheo E; Méndez C; Del Amo M; Balseiro C;
Vaccine; 2017 Aug; 35(35 Pt B):4646-4651. PubMed ID: 28711388
[TBL] [Abstract][Full Text] [Related]
14. Impact of pneumococcal conjugate vaccine in children on the serotypic epidemiology of adult invasive pneumococcal diseases in Taiwan.
Chi HC; Hsieh YC; Tsai MH; Lee CH; Kuo KC; Huang CT; Huang YC
J Microbiol Immunol Infect; 2018 Jun; 51(3):332-336. PubMed ID: 28082066
[TBL] [Abstract][Full Text] [Related]
15. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.
Waight PA; Andrews NJ; Ladhani SN; Sheppard CL; Slack MP; Miller E
Lancet Infect Dis; 2015 May; 15(5):535-43. PubMed ID: 25801458
[TBL] [Abstract][Full Text] [Related]
16. Colonization with 19F and other pneumococcal conjugate vaccine serotypes in children in St. Louis, Missouri, USA.
McFarland M; Szasz TP; Zhou JY; Motley K; Sivapalan JS; Isaacson-Schmid M; Todd EM; Hogan PG; Fritz SA; Burnham CD; Hoffmann S; Morley SC
Vaccine; 2017 Aug; 35(34):4389-4395. PubMed ID: 28687405
[TBL] [Abstract][Full Text] [Related]
17. Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012.
Demczuk WH; Martin I; Griffith A; Lefebvre B; McGeer A; Lovgren M; Tyrrell GJ; Desai S; Sherrard L; Adam H; Gilmour M; Zhanel GG; ;
Can J Microbiol; 2013 Dec; 59(12):778-88. PubMed ID: 24313450
[TBL] [Abstract][Full Text] [Related]
18. Streptococcus pneumoniae serotypes isolated from the middle ear fluid of Costa Rican children following introduction of the heptavalent pneumococcal conjugate vaccine into a limited population.
Guevara S; Abdelnour A; Soley C; Porat N; Dagan R; Arguedas A
Vaccine; 2012 Jun; 30(26):3857-61. PubMed ID: 22521846
[TBL] [Abstract][Full Text] [Related]
19. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?
Fenoll A; Aguilar L; Granizo JJ; Giménez MJ; Aragoneses-Fenoll L; Mendez C; Tarragó D
J Antimicrob Chemother; 2008 Dec; 62(6):1430-3. PubMed ID: 18819966
[TBL] [Abstract][Full Text] [Related]
20. Serotype replacement of Streptococcus pneumoniae due to seven-valent pneumococcal conjugate vaccine in Japan.
Sakata H; Sato Y; Toyonaga Y; Hanaki H;
Pediatr Int; 2018 Jan; 60(1):52-56. PubMed ID: 28779495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
